Related Experiment Video
Updated: Aug 9, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon-alpha: mechanisms of action in chronic myelogenous leukemia in chronic phase
1Département d'Hématologie et Oncologie Médicale, Hôpital Jean Bernard, CHU la Milétrie, Poitiers, France.
Insights
Interferon-alpha (IFN-alpha) effectively treats chronic myelogenous leukemia (CML) by inducing hematologic and cytogenetic responses, improving patient survival. Its multifaceted action involves direct anti-leukemic effects and immune modulation.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm.
- Interferon-alpha (IFN-alpha) is a therapeutic agent used in CML treatment.
- Cytogenetic responses correlate with improved survival in CML patients.
Purpose of the Study:
- To summarize the effects of Interferon-alpha (IFN-alpha) in chronic myelogenous leukemia (CML).
- To highlight the correlation between cytogenetic response and survival.
- To elucidate the diverse mechanisms of action of IFN-alpha.
Main Methods:
- Review of existing literature on Interferon-alpha (IFN-alpha) in CML.
- Analysis of clinical response data (hematologic and cytogenetic).
- Examination of proposed molecular and cellular mechanisms of IFN-alpha.
Main Results:
- IFN-alpha induces complete hematologic and cytogenetic responses in CML patients.
- A strong correlation exists between cytogenetic response and enhanced survival.
- IFN-alpha exhibits multiple mechanisms, including direct anti-leukemic effects and immune stimulation.
Conclusions:
- Interferon-alpha (IFN-alpha) is an effective treatment for chronic myelogenous leukemia (CML), improving survival through various biological pathways.
- Understanding the multifaceted mechanisms of IFN-alpha is crucial for optimizing CML therapy.
- Cytogenetic response serves as a key indicator of treatment efficacy and prognostic value in CML.
Abstract:
Interferon-alpha has been shown to induce complete haematologic responses in chronic myelogenous leukemia patients and also cytogenetic responses. There is a clear correlation between cytogenetic responses and survival improvement. There is not a unique mechanism of action of IFN-alpha. IFN-alpha acts directly against leukemic cells and there are also other mechanisms of action such as immune stimulation, gene regulation and growth factors or interleukin stimulation.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis
Chronic Inflammation: Introduction

